Modular design of a novel chimeric protein with combined thrombin inhibitory activity and plasminogen-activating potential

Molecular Genetics and Metabolism
F WirschingA Schwienhorst

Abstract

In order to design plasminogen activators with improved thrombolytic properties we sought to construct the bifunctional protein HLS-2 which combines both a plasminogen-activating and an anticoagulative activity. The chimeric protein comprises four elements: a derivative of thrombin inhibitor hirudin, a 6-amino acid spacer, the sequence of plasminogen-activator staphylokinase (Sak), and a 13-amino acid expression tag at the C-terminus. The gene of the fusion protein was obtained by SOE-PCR, cloned into pCANTAB5E, and expressed in E. coli BL21. HLS-2 was purified from periplasmatic extracts and characterized by Western blotting. Plasminogen-activation of HLS-2 and of Sak in equimolar mixtures with plasminogen showed near equivalence as measured by plasmin-mediated cleavage of chromogenic substrate S-2403. For catalytic amounts of plasminogen-activator, however, HLS-2 was less effective by a factor of 1.7. HLS-2 also inhibited both the amidolytic and the fibrinolytic activities of thrombin. Similar concentrations of either commercial HV1 (42 pmol/L) or HLS-2 (250 pmol/L) were required to halve the initial rate of thrombin reaction with fluorogenic substrate Tos-Gly-Pro-Arg-AMC, suggesting the retention of high-affinity inhibition ...Continue Reading

References

Nov 22, 1990·The New England Journal of Medicine·H K Gold
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P J Hogg, C M Jackson
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S HustonR Crea
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R P HarveyJ P Lecocq
Feb 27, 1986·Journal of Immunological Methods·S SpinnerE Fink
Jan 1, 1995·Trends in Biochemical Sciences·M T Stubbs, W Bode
Oct 29, 1993·Biochemical and Biophysical Research Communications·Y KomatsuH Hayashi
Dec 16, 1993·The American Journal of Cardiology·D Collen, H R Lijnen
Feb 28, 1997·The Journal of Biological Chemistry·B SchlottD Collen
Apr 1, 1997·Journal of Biomolecular NMR·O OhlenschlägerL R Brown

❮ Previous
Next ❯

Citations

May 10, 2007·Journal of Thrombosis and Thrombolysis·Bingxing ShiChutse Wu
Aug 9, 2006·Acta Biochimica Et Biophysica Sinica·Yu-Gao ZhangHou-Yan Song
Dec 5, 2003·Molecular Genetics and Metabolism·Frank WirschingAndreas Schwienhorst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.